Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1582 per EA under NDC 33342026807. Its NADAC has been published 319 times since Jul 15, 2020.

FDA first approved this application on Oct 7, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

Tadalafil
$0.1582per EA

Strength

20 mg/1

NDC

33342026807

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA207244

FDA Approved

10/7/2019

TE Code

AB1

On Market Since

10/8/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 319 times since Jul 15, 2020, and over the history we have for it it has declined 73.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1582 per EA
All-time high$0.7016 (Sep 16, 2020)
All-time low$0.1568 (Nov 20, 2024)
52-week high$0.2171
52-week low$0.1582
Median price$0.3043
Average price$0.3273
Largest weekly change+57.2% (Sep 21, 2022)
Weeks tracked319
Tracking sinceJul 15, 2020

Price History

1W

-2.7%

1M

-2.7%

3M

-11.9%

6M

-17.7%

1Y

-27.2%

3Y

-50.2%

5Y

-63.9%

All

-73.9%

Generic Alternatives

The matcher finds 18 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1582 per EA (NDC 33342026807), effective Aug 19, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 73.9%. It has been tracked across 319 weekly CMS publications since Jul 15, 2020.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since Jul 15, 2020, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1568 (Nov 20, 2024) to a high of $0.7016 (Sep 16, 2020), with a median of $0.3043 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

Yes. 18 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYQ 20 MG TABLET, is $0.1400 per EA — about 11% below TADALAFIL 20 MG TABLET.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 33342026807) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.